Induction of ovulation with luprolide acetate and human menopausal gonadotropin
- 1 April 1988
- journal article
- research article
- Published by Elsevier in Fertility and Sterility
- Vol. 49 (4) , 585-588
- https://doi.org/10.1016/s0015-0282(16)59822-7
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- The Effect of Leuprolide Acetate on Ovulation Induction with Human Menopausal Gonadotropins in Polycystic Ovary Syndrome*Journal of Clinical Endocrinology & Metabolism, 1987
- Therapeutic Uses of Gonadotropin-Releasing Hormone AnalogsObstetrical & Gynecological Survey, 1987
- Intranasal peptide contraception by inhibition of ovulation with the gonadotropin-releasing hormone superagonist nafarelin: six months' clinical resultsFertility and Sterility, 1986
- Successful treatment of infertile women with oligomenorrhoea using a combination of an LHRH agonist and exogenous gonadotrophinsBJOG: An International Journal of Obstetrics and Gynaecology, 1985
- Reversible hypogonadism induced by a luteinizing hormone-releasing hormone (LH-RH) agonist (Buserelin) as a new therapeutic approach for endometriosisFertility and Sterility, 1984
- Preliminary report about a modified gonadotropin (human menopausal gonadotropin/human chorionic gonadotropin) treatment in infertile patients with premature luteinizationFertility and Sterility, 1984
- Peptide Contraception in WomenUpsala Journal of Medical Sciences, 1984
- Intranasal treatment with luteinising hormone releasing hormone agonist in women with endometriosis.BMJ, 1983
- SUSTAINED GONADAL SUPPRESSION IN FERTILE WOMEN WITH THE LHRH AGONIST BUSERELINClinical Endocrinology, 1983
- Absence of gonadotropin-releasing hormone receptors in human gonadal tissueNature, 1982